Jasmine L. DeVinney

Jasmine L. DeVinney serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements development through contract award and administration. She plays a critical role in ensuring compliance with federal procurement regulations while advancing mission-critical capabilities for her agency. Her portfolio primarily consists of complex procurements in the life sciences and laboratory technology sectors, including both service-based contracts and hardware acquisitions for specialized analytical equipment. DeVinney is known for her methodical approach to market research, source selection, and contract negotiation, ensuring transparency and value in every procurement action. While specific contractor relationships are not publicly detailed, DeVinney consistently engages with a diverse range of vendors, including large-scale manufacturers of laboratory instruments, diagnostic substance producers, and industrial gas suppliers. Her contracting patterns reflect a preference for established industry players with proven technical expertise, alongside active engagement with small businesses that meet stringent performance and compliance standards. She maintains collaborative, performance-driven relationships with contractors, emphasizing accountability, deliverable alignment, and post-award oversight. DeVinney’s procurement activity is entirely focused on open competition, with 100% of her awards designated as “No Set-Aside.” This reflects a strategic emphasis on technical merit and market-wide competition rather than socioeconomic set-asides. While she does not prioritize 8(a), HUBZone, or SDVOSB programs, her process remains fully compliant with small business participation goals, and she actively encourages qualified small businesses to compete on an equal footing through clear solicitation language and accessible market research. Her primary NAICS focus areas include Medical Laboratories (621511), Analytical Laboratory Instrument Manufacturing (334516), and In-Vitro Diagnostic Substance Manufacturing (325413), demonstrating deep expertise in clinical diagnostics, laboratory automation, and specialty chemical supply chains. She routinely procures high-precision analytical equipment, reagents, and testing services critical to public health and scientific research, positioning her as a key technical procurement authority in the life sciences domain.